Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of RO7837195 injection compared to placebo to treat moderate to severe ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Italy Poland
  • Comparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany
  • Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Bulgaria Czechia Denmark France Germany +8
  • Study on Vedolizumab and Ustekinumab for Patients with Crohn’s Disease and Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study on Reducing Vedolizumab Dosage for Patients with Inflammatory Bowel Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Croatia Czechia Denmark France Germany +8
  • Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Hungary Poland
  • Exploring Precision Dosing of Infliximab for Patients with Steroid-Resistant Severe Ulcerative Colitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium
  • Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Croatia Greece Hungary Italy Poland
  • Study on Stopping Infliximab and Adalimumab Treatment in Patients with Crohn’s Disease and Ulcerative Colitis in Remission

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden